Skip to main content

Table 6 Baseline characteristics of the participants in the intervention group and control group

From: The role of text messaging intervention in Inner Mongolia among patients with type 2 diabetes mellitus: a randomized controlled trial

 

Total

IG (n = 85)

CG (n = 86)

t/χ2

P value

Demographic, Mean (SD)

 Gender (Male/Female)

97/74

42/43

55/31

3.682

0.055

 Age (years)

55.1 (10.8)

55.4 (9.7)

54.7 (11.8)

−0.416

0.678

 BMI (Kg/m2)

25.8 (3.8)

25.9 (3.5)

25.8 (4.1)

−0.255

0.799

Indicators, Mean (SD)

 FPG (mmol/L)

9.0 (2.6)

9.2 (2.8)

8.8 (2.4)

−0.954

0.342

 PPG (mmol/L)

16.6 (4.4)

16.8 (4.6)

16.4 (4.3)

−0.599

0.550

 SBP (mmHg)

132.3 (17.0)

131.0 (16.1)

134.3 (17.8)

1.137

0.257

 DBP (mmHg)

80.8 (11.8)

79.8 (9.8)

81.8 (13.5)

1.034

0.303

 FPG control (%)

48 (28.4)

25 (29.8)

23 (27.1)

0.152

0.697

 PPG control (%)

16 (9.6)

10 (12.0)

6 (7.2)

1.107

0.293

 SBP control (%)

90 (60.8)

51 (68.0)

39 (53.4)

3.298

0.069

 DBP control (%)

92 (63.4)

50 (68.5)

42 (58.3)

1.613

0.204

 Total cholesterol (mg/l)

4.7 (1.2)

4.8 (1.2)

4.7 (1.2)

−0.747

0.456

 Triglycerides (mg/l)

1.9 (1.3)

1.9 (1.3)

1.9 (1.2)

0.275

0.783

 HDL-C (mg/l)

1.1 (0.3)

1.1 (0.2)

1.1 (0.3)

−1.062

0.290

 LDL-C (mg/l)

3.0 (0.9)

3.0 (0.9)

2.9 (1.0)

−0.739

0.461

 HbAlC (%)

9.2 (2.0)

9.2 (2.0)

9.1 (2.0)

−0.339

0.735

Risk factors

 Hypertension (%)

65 (39.6)

32 (39.0)

33 (40.2)

0.025

0.873

 Dyslipidemia (%)

96 (56.1)

46 (54.1)

50 (58.1)

0.126

0.722

 Smoking (%)

44 (25.7)

23 (27.1)

21 (24.4)

0.156

0.693

 Drinking (%)

58 (33.9)

26 (30.6)

32 (37.2)

0.361

0.836

 Overweight (%)

97 (58.1)

50 (61.0)

47 (55.3)

0.553

0.457

 Pain (%)

94 (55.3)

41 (48.2)

53 (62.4)

3.427

0.064

 Anxiety (%)

82 (48.2)

43 (50.6)

39 (45.9)

0.377

0.539

 Hypoglycemic therapy (%)

156 (94.0)

80 (97.6)

76 (90.5)

2.534

0.111

Medication way (%)

   

3.058

0.217

 insulin

80 (51.9)

46 (57.5)

34 (45.9)

  

 Oral medication + insulin

48 (31.2)

20 (25.0)

28 (37.8)

  

 Oral medication

26 (16.9)

14 (17.5)

12 (16.2)

  

 Antihypertensive therapy (%)

60 (35.1)

31 (36.5)

29 (33.7)

 

0.672†

  1. CG control group, IG intervention group, SD standard deviation, BMI body mass index, FPG fasting plasma glucose, PPG postprandial glucose, SBP systolic blood pressure, DBP diastolic blood pressure, HDL-C high density lipoprotein-c, LDL-C low density lipoprotein-c
  2. †Fisher probabilities method